OMEPRAZOL Mepha caps 10 mg bte 98 pce

7680628750322 CH-62875 A02BC01 04.99.0.

Active substances:

OMEPRAZOL Mepha caps 10 mg bte 98 pce
OMEPRAZOL Mepha caps 10 mg bte 98 pce
OMEPRAZOL Mepha caps 10 mg bte 98 pce
1 / 3
google

Details

Product number
6287501
CPT
-
Packaging group
98
Unit
Kapsel(n)
Composition
omeprazolum 10 mg, sacchari sphaerae corresp. saccharum 40.01 mg, povidonum K 30, natrii laurilsulfas, carboxymethylamylum natricum A, trinatrii phosphas dodecahydricus, hypromellosum, triethylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii hydroxidum, talcum, E 171, Kapselhülle: aqua, gelatina, E 171, Drucktinte: lacca, ethanolum anhydricum, alcohol isopropylicus, propylenglycolum, alcohol butylicus, ammonii hydroxidum, kalii hydroxidum, aqua purificata, E 172 (nigrum), pro capsula corresp. natrium 0.45 mg.

Articles (1)

Omeprazol-Mepha 10 mg, magensaftresistente Kapseln
Magensaftresistente Kapseln
98
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/07/2024
Patient information leaflet
Français
16/07/2024
Patient information leaflet
Italien
16/07/2024
Professional SmPC
Allemand
16/07/2024
Professional SmPC
Français
16/07/2024
Professional SmPC
Italien
16/07/2024

Detailed composition

Substance Quantity Type Category
omeprazolum
10.0 MG Substance Wirkstoff (Principe actif)
sacchari sphaerae
- Substance HNIDK
saccharum
40.01 MG Substance HBESI
povidonum K 30
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
carboxymethylamylum natricum A
- Substance HNIDK
trinatrii phosphas dodecahydricus
- Substance HNIDK
hypromellosum
- Substance HNIDK
triethylis citras
- Substance HNIDK
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK
aqua
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
lacca
- Substance HNIDK
ethanolum anhydricum
- Substance HNIDK
alcohol isopropylicus
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
alcohol butylicus
- Substance HNIDK
ammonii hydroxidum
- Substance HNIDK
kalii hydroxidum
- Substance HNIDK
aqua purificata
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
natrium
0.45 MG Substance HBESI

Reimbursement information

Public price
CHF 35.20
Specialties list
Yes
Generic
Yes
SL addition date: 01/01/2015

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
62875
Drug name
Omeprazol-Mepha, magensaftresistente Kapseln
Galenic form
KAHAM
ATC Code
A02BC01
Authorization status
Z
Dispensation category
B
First authorization
20/11/2013
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
Ulcustherapie, Zollinger-Ellison-Syndrom

Packaging details

Description (FR)
OMEPRAZOL Mepha caps 10 mg bte 98 pce
Description (DE)
OMEPRAZOL Mepha Kaps 10 mg Ds 98 Stk
Market launch
20/11/2013
Narcotic (BTM)
No

Original drug

Antramups, Tabletten
CHF 16.20
View original

Other packaging sizes

OMEPRAZOL Mepha caps 10 mg bte 14 pce
14 KAP
View
OMEPRAZOL Mepha caps 10 mg bte 28 pce
28 KAP
View
OMEPRAZOL Mepha caps 10 mg bte 56 pce
56 KAP
View
Buy us a coffee Explore the data